Eli Lilly and Co (LLY)
748.01
-1.91
(-0.25%)
USD |
NYSE |
Nov 22, 16:00
747.05
-0.96
(-0.13%)
After-Hours: 20:00
Eli Lilly Price: 748.01 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 755.00 | 761.28 | 745.08 | 748.01 | 3.570M |
| Nov 21, 2024 | 746.12 | 753.00 | 735.00 | 749.92 | 4.143M |
| Nov 20, 2024 | 735.78 | 757.37 | 735.46 | 753.41 | 5.159M |
| Nov 19, 2024 | 716.31 | 730.00 | 712.42 | 729.73 | 5.832M |
| Nov 18, 2024 | 733.19 | 734.00 | 711.40 | 727.20 | 9.154M |
| Nov 15, 2024 | 775.19 | 777.98 | 744.20 | 746.20 | 7.335M |
| Nov 14, 2024 | 809.19 | 809.19 | 783.51 | 786.23 | 3.999M |
| Nov 13, 2024 | 820.32 | 829.10 | 811.29 | 811.81 | 3.059M |
| Nov 12, 2024 | 830.20 | 833.99 | 810.72 | 818.86 | 3.379M |
| Nov 11, 2024 | 831.30 | 844.00 | 824.62 | 832.44 | 3.343M |
| Nov 08, 2024 | 803.50 | 847.27 | 801.26 | 831.54 | 7.213M |
| Nov 07, 2024 | 784.65 | 802.55 | 778.19 | 797.45 | 4.558M |
| Nov 06, 2024 | 817.33 | 820.73 | 767.61 | 776.38 | 8.258M |
| Nov 05, 2024 | 803.82 | 809.21 | 797.49 | 806.06 | 3.733M |
| Nov 04, 2024 | 805.00 | 820.19 | 803.68 | 806.14 | 3.918M |
| Nov 01, 2024 | 828.00 | 833.00 | 816.73 | 818.93 | 5.266M |
| Oct 31, 2024 | 836.51 | 853.50 | 825.24 | 829.74 | 6.583M |
| Oct 30, 2024 | 798.50 | 860.50 | 769.00 | 846.83 | 18.26M |
| Oct 29, 2024 | 898.21 | 907.98 | 898.21 | 903.58 | 3.188M |
| Oct 28, 2024 | 894.87 | 898.21 | 890.78 | 895.59 | 2.084M |
| Oct 25, 2024 | 899.73 | 900.96 | 889.45 | 892.70 | 2.228M |
| Oct 24, 2024 | 898.33 | 900.00 | 888.28 | 891.32 | 1.797M |
| Oct 23, 2024 | 905.62 | 907.95 | 891.73 | 903.25 | 2.647M |
| Oct 22, 2024 | 901.68 | 911.12 | 900.20 | 909.15 | 1.392M |
| Oct 21, 2024 | 917.98 | 918.86 | 904.56 | 906.13 | 1.592M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
116.74
Minimum
Dec 02 2019
960.02
Maximum
Aug 30 2024
377.79
Average
301.28
Median
Price Benchmarks
| Amgen Inc | 294.53 |
| Biogen Inc | 157.90 |
| Johnson & Johnson | 155.17 |
| Viking Therapeutics Inc | 52.59 |
| Moderna Inc | 41.11 |
Price Related Metrics
| PE Ratio | 80.87 |
| PS Ratio | 16.55 |
| PEG Ratio | 1.144 |
| Price to Book Value | 49.87 |
| Earnings Yield | 1.24% |
| Market Cap | 710.10B |
| PEGY Ratio | 1.133 |
| Operating PE Ratio | 44.71 |
| Normalized PE Ratio | 59.95 |